Bravo-Gómez, A.; Salvador-MartÃn, S.; Zapata-Cobo, P.; Sanjurjo-Sáez, M.; López-Fernández, L.A.
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain. Pharmaceutics 2022, 14, 2082.
https://doi.org/10.3390/pharmaceutics14102082
AMA Style
Bravo-Gómez A, Salvador-MartÃn S, Zapata-Cobo P, Sanjurjo-Sáez M, López-Fernández LA.
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain. Pharmaceutics. 2022; 14(10):2082.
https://doi.org/10.3390/pharmaceutics14102082
Chicago/Turabian Style
Bravo-Gómez, Adrián, Sara Salvador-MartÃn, Paula Zapata-Cobo, MarÃa Sanjurjo-Sáez, and Luis Andrés López-Fernández.
2022. "Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain" Pharmaceutics 14, no. 10: 2082.
https://doi.org/10.3390/pharmaceutics14102082
APA Style
Bravo-Gómez, A., Salvador-MartÃn, S., Zapata-Cobo, P., Sanjurjo-Sáez, M., & López-Fernández, L. A.
(2022). Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain. Pharmaceutics, 14(10), 2082.
https://doi.org/10.3390/pharmaceutics14102082